Recent progress in translational engineered in vitro models of the central nervous system

P Nikolakopoulou, R Rauti, D Voulgaris, I Shlomy… - Brain, 2020 - academic.oup.com
The complexity of the human brain poses a substantial challenge for the development of
models of the CNS. Current animal models lack many essential human characteristics (in …

Variable selection methods in QSAR: an overview

MP Gonzalez, C Teran, L Saiz-Urra… - Current topics in …, 2008 - ingentaconnect.com
Variable selection is a procedure used to select the most important features to obtain as
much information as possible from a reduced amount of features. The selection stage is …

[HTML][HTML] A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations

TS Carpenter, DA Kirshner, EY Lau, SE Wong… - Biophysical journal, 2014 - cell.com
The blood-brain barrier (BBB) is formed by specialized tight junctions between endothelial
cells that line brain capillaries to create a highly selective barrier between the brain and the …

In vivo, in vitro and in silico methods for small molecule transfer across the BBB

J Mensch, J Oyarzabal, C Mackie… - Journal of pharmaceutical …, 2009 - Elsevier
The inability of molecules to permeate the BBB is a significant source of attrition in Central
Nervous System (CNS) drug discovery. Given the increasing medical drivers for new and …

Recent advances in computational prediction of drug absorption and permeability in drug discovery

T Hou, J Wang, W Zhang, W Wang… - Current medicinal …, 2006 - ingentaconnect.com
Approximately 40%-60% of developing drugs failed during the clinical trials because of
ADME/Tox deficiencies. Virtual screening should not be restricted to optimize binding affinity …

The role of blood-brain barrier studies in the pharmaceutical industry

A Reichel - Current drug metabolism, 2006 - ingentaconnect.com
The blood-brain barrier (BBB) remains one of the greatest challenges for the discovery and
development of treatments for CNS disorders, which to this day remains one of the riskiest …

In silico prediction of blood brain barrier permeability: an artificial neural network model

P Garg, J Verma - Journal of chemical information and modeling, 2006 - ACS Publications
This paper has two objectives: first to develop an in silico model for the prediction of blood
brain barrier permeability of new chemical entities and second to find the role of active …

A data base for partition of volatile organic compounds and drugs from blood/plasma/serum to brain, and an LFER analysis of the data

MH Abraham, A Ibrahim, Y Zhao… - Journal of Pharmaceutical …, 2006 - Elsevier
Literature values of the in vivo distribution (BB) of drugs from blood, plasma, or serum to rat
brain have been assembled for 207 compounds (233 data points). We find that data on in …

Recent developments of in silico predictions of intestinal absorption and oral bioavailability

T Hou, Y Li, W Zhang, J Wang - Combinatorial Chemistry & …, 2009 - ingentaconnect.com
Among the absorption, distribution, metabolism, elimination, and toxicity properties
(ADMET), unfavorable oral bioavailability is indeed an important reason for stopping further …

Benchmarking of QSAR models for blood-brain barrier permeation

DA Konovalov, D Coomans, E Deconinck… - Journal of chemical …, 2007 - ACS Publications
Using the largest available database of 328 blood− brain distribution (logBB) values, a
quantitative benchmark was proposed to allow for a consistent comparison of the predictive …